Align Technology | ALGN - Cash And Equivalent

Stock Price
177.28
Daily Change
-7.42 -4.02%
Monthly
6.63%
Yearly
-0.26%
Q2 Forecast
185.55

Align Technology reported $1B in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
3M USD 3.73B 1.51B Mar/2026
Align Technology USD 1B 103.43M Sep/2025
Becton, Dickinson and Co. USD 740M 99M Dec/2025
Bruker USD 293.1M 201.1M Sep/2025
Cardinal Health USD 2.78B 1.82B Dec/2025
Charles River Laboratories USD 213.77M 6.67M Dec/2025
Cooper Companies USD 110.6M 14.3M Sep/2025
CVS Health USD 8.45B 645M Dec/2025
Danaher USD 5.7B 1.09B Mar/2026
Dentsply International USD 326M 37M Dec/2025
Dexcom USD 917.7M 918M Dec/2025
Henry Schein USD 136M 9M Sep/2025
Idexx Laboratories USD 180.07M 28.1M Dec/2025
Insulet USD 716.1M 41.3M Dec/2025
Integra LifeSciences USD 235.05M 2.86M Dec/2025
IQVIA Holdings USD 1.98B 166M Dec/2025
Masimo USD 312.3M 162.7M Sep/2025
McKesson USD 2.96B 1.05B Dec/2025
Mettler Toledo International USD 69.06M 7.24M Sep/2025
Revvity USD 919.86M 11.53M Dec/2025
Solventum Corp USD 878M 764M Dec/2025
Stryker USD 4.01B 755M Dec/2025
Teleflex USD 354M 100.3M Sep/2025
Thermo Fisher Scientific USD 3.25B 6.6B Mar/2026
Veeva Systems USD 1.42B 238.9M Dec/2025
Waters USD 587.83M 128.71M Dec/2025
Zimmer Biomet Holdings USD 591.9M 700.8M Dec/2025
Zoetis USD 2.08B 649M Sep/2025